Noticias de JBIO_US

Noticias del mercado

Últimas noticias sobre JBIO_US — 250 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: JBIO_US ✕ 250 resultados
22/05/2026 JBIO_US — thelegaladvocate.com ES ← EN
Jade Biosciences Inc. (JBIO) se mantiene estable mientras el precio se consolida cerca de la resistencia clave: taza y mango

Jade Biosciences Inc. (JBIO) Holds Steady as Price Consolidates Near Key Resistance - Cup and Handle

17/05/2026 JBIO_US — Stock Titan
[EFFECT] Jade Biosciences, Inc. SEC Filing
17/05/2026 JBIO_US — Stock Titan
[EFFECT] Jade Biosciences, Inc. SEC Filing
15/05/2026 JBIO_US — TradingView ES ← EN
Jade Biosciences Inc - Folleto presentado para la reventa de hasta 39.542.339 acciones por parte de los accionistas vendedores - Presentación a la SEC

Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing

15/05/2026 JBIO_US — MarketScreener
Jade Biosciences Inc - Prospectus filed for resale of up to 39,542,339 shares by selling stockholders - SEC filing
15/05/2026 JBIO_US — Stock Titan
Jade Biosciences (JBIO) registers 39.5M shares for resale by PIPE and early investors
15/05/2026 JBIO_US — Stock Titan
Janus Henderson (JBIO) discloses 3,105,669-share, 6.3% holding in Jade Biosciences
15/05/2026 JBIO_US — MSN
Jade Biosciences (JBIO) price target increased by 16.48% to 26.14
15/05/2026 JBIO_US — MSN
Jade Biosciences (JBIO) price target increased by 16.48% to 26.14
11/05/2026 JBIO_US — MarketBeat
Jade Biosciences (NASDAQ:JBIO) Given New $34.00 Price Target at Wedbush
09/05/2026 JBIO_US — MarketBeat
Jade Biosciences (NASDAQ:JBIO) Cut to "Sell" at Wall Street Zen
08/05/2026 JBIO_US — The Manila Times
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
07/05/2026 JBIO_US — Newser
Why Jade Biosciences (JBIO) looks attractive at current levels (Edges Lower) 2026-05-07 - Investment Community Signals
07/05/2026 JBIO_US — newser.com ES ← EN
Por qué Jade Biosciences (JBIO) parece atractivo en los niveles actuales (Bordes inferiores) 2026-05-07 - Riesgo a la baja

Why Jade Biosciences (JBIO) looks attractive at current levels (Edges Lower) 2026-05-07 - Downside Risk

07/05/2026 JBIO_US — MarketScreener ES ← EN
Jade Biosciences Inc puede ofrecer y vender hasta 600 millones de dólares en valores: presentación ante la SEC

Jade Biosciences Inc may offer and sell up to $600 million of securities - SEC filing

07/05/2026 JBIO_US — TradingView
Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing
07/05/2026 JBIO_US — Stock Titan
Jade Biosciences (JBIO) ramps R&D with $40.4M loss and $311M cash
07/05/2026 JBIO_US — TradingView
BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million

07 mayo (Reuters) - Ingresos netos del primer trimestre de Jade Biosciences, Inc -40,4 millones de dólares frente a la estimación de IBES -32,5 millones de dólares.

07/05/2026 JBIO_US — ChartMill
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
07/05/2026 JBIO_US — Newser
Why Jade Biosciences (JBIO) looks attractive at current levels (Edges Lower) 2026-05-07 - Fed Rate Impact

Página 7 de 13

keyboard_arrow_up